SDC1 and acute kidney injury: Although AGPT2 and syndecan-1 are not biomarkers specific to kidney structure, both are related to AKI development under several conditions23–26, endothelial injury has an important role in AKI pathophysiology, and both biomarkers can be released from the glomerular endothelium when the kidneys suffer inflammatory injury27.